Regeneron Pharmaceuticals
REGN
#231
Rank
HK$599.27 B
Marketcap
HK$5,453
Share price
-0.90%
Change (1 day)
-17.06%
Change (1 year)

Regeneron Pharmaceuticals (REGN) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : HK$63.06 Billion

According to Regeneron Pharmaceuticals's latest financial reports the company's total liabilities are HK$63.06 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Regeneron Pharmaceuticals - Total liabilities on balance sheet (from 2001 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31HK$55.50 B8.45%
2022-12-31HK$51.18 B-1.53%
2021-12-31HK$51.97 B9.24%
2020-12-31HK$47.58 B64.44%
2019-12-31HK$28.93 B24.12%
2018-12-31HK$23.31 B13.89%
2017-12-31HK$20.47 B4.58%
2016-12-31HK$19.57 B29.23%
2015-12-31HK$15.14 B51.69%
2014-12-31HK$9.98 B28.91%
2013-12-31HK$7.74 B19.67%
2012-12-31HK$6.47 B-0.53%
2011-12-31HK$6.50 B48.89%
2010-12-31HK$4.37 B63.65%
2009-12-31HK$2.67 B14.17%
2008-12-31HK$2.33 B-36.97%
2007-12-31HK$3.71 B29.51%
2006-12-31HK$2.86 B19.42%
2005-12-31HK$2.39 B6.27%
2004-12-31HK$2.25 B-14.8%
2003-12-31HK$2.65 B38.37%
2002-12-31HK$1.91 B7.24%
2001-12-31HK$1.78 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
HK$647.67 B 927.06%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$32.42 B-48.59%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$92.88 B 47.29%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$840.16 B 1,232.29%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$466.84 B 640.30%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
HK$472.75 B 649.68%๐Ÿ‡ซ๐Ÿ‡ท France